High Density Lipoprotein pathway as a therapeutic target for coronary heart disease: individual participant meta-analysis in 28,597 individuals with 4197 coronary events
View ORCID ProfileAmy R Mulick, David Prieto-Merino, Therese Tillin, Aki Havulinna, Martin Shipley, Desiree Valera-Gran, Aleksandra Gentry-Maharaj, Andy Ryan, Meena Kumari, J Wouter Jukema, Alex McConnachie, Veikko Salomaa, Nish Chaturvedi, Goya Wannamethee, Usha Menon, Barbara Jefferis, Mika Kivimaki, Chris J Packard, Naveed Sattar, John Whittaker, Aroon Hingorani, George B Ploubidis, JP Casas
doi: https://doi.org/10.1101/2020.03.02.19010173
Amy R Mulick
1Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK
MScDavid Prieto-Merino
1Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK
2Applied Statistical Methods in Medical Research Group, Universidad Catolica San Antonio de Murcia, Spain
PhDTherese Tillin
3Institute of Cardiovascular Science, University College London, London, UK
MScAki Havulinna
4National Institute for Health and Welfare, Helsinki, Finland
DSc(Tech)Martin Shipley
5Department of Epidemiology and Public Health, University College London, London, UK
MScDesiree Valera-Gran
6Department of Pathology and Surgery, Miguel Hernández University, San Juan de Alicante, Spain
PhDAleksandra Gentry-Maharaj
7MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK
PhDAndy Ryan
7MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK
PhDMeena Kumari
8Institute for Social and Economic Research, University of Essex, Essex, UK
PhDJ Wouter Jukema
9Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
MD PhD FESC FACCAlex McConnachie
10Institute of Health and Wellbeing, Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK
PhDVeikko Salomaa
4National Institute for Health and Welfare, Helsinki, Finland
MD PhD Research ProfessorNish Chaturvedi
3Institute of Cardiovascular Science, University College London, London, UK
MDGoya Wannamethee
11Department of Primary Care & Population Health, University College London, Royal Free Campus, London, UK
PhD FFPHUsha Menon
7MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK
MDBarbara Jefferis
11Department of Primary Care & Population Health, University College London, Royal Free Campus, London, UK
PhDMika Kivimaki
5Department of Epidemiology and Public Health, University College London, London, UK
FMedSciChris J Packard
12Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK
DScNaveed Sattar
12Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK
FMedSciJohn Whittaker
13Target Sciences, Glaxo-Smith-Kline, Stevenage, UK
PhDAroon Hingorani
3Institute of Cardiovascular Science, University College London, London, UK
PhDGeorge B Ploubidis
14Centre for Longitudinal Studies, UCL Institute of Education, University College London, London, UK
PhDJP Casas
15Institute of Health Informatics, University College London, UK
16Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, USA
PhD
Posted March 06, 2020.
High Density Lipoprotein pathway as a therapeutic target for coronary heart disease: individual participant meta-analysis in 28,597 individuals with 4197 coronary events
Amy R Mulick, David Prieto-Merino, Therese Tillin, Aki Havulinna, Martin Shipley, Desiree Valera-Gran, Aleksandra Gentry-Maharaj, Andy Ryan, Meena Kumari, J Wouter Jukema, Alex McConnachie, Veikko Salomaa, Nish Chaturvedi, Goya Wannamethee, Usha Menon, Barbara Jefferis, Mika Kivimaki, Chris J Packard, Naveed Sattar, John Whittaker, Aroon Hingorani, George B Ploubidis, JP Casas
medRxiv 2020.03.02.19010173; doi: https://doi.org/10.1101/2020.03.02.19010173
High Density Lipoprotein pathway as a therapeutic target for coronary heart disease: individual participant meta-analysis in 28,597 individuals with 4197 coronary events
Amy R Mulick, David Prieto-Merino, Therese Tillin, Aki Havulinna, Martin Shipley, Desiree Valera-Gran, Aleksandra Gentry-Maharaj, Andy Ryan, Meena Kumari, J Wouter Jukema, Alex McConnachie, Veikko Salomaa, Nish Chaturvedi, Goya Wannamethee, Usha Menon, Barbara Jefferis, Mika Kivimaki, Chris J Packard, Naveed Sattar, John Whittaker, Aroon Hingorani, George B Ploubidis, JP Casas
medRxiv 2020.03.02.19010173; doi: https://doi.org/10.1101/2020.03.02.19010173
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2300)
- Dermatology (205)
- Emergency Medicine (372)
- Epidemiology (11633)
- Forensic Medicine (10)
- Gastroenterology (685)
- Genetic and Genomic Medicine (3638)
- Geriatric Medicine (342)
- Health Economics (624)
- Health Informatics (2335)
- Health Policy (921)
- Hematology (336)
- HIV/AIDS (761)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3393)
- Nursing (193)
- Nutrition (512)
- Oncology (1783)
- Ophthalmology (527)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6031)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (144)